CLINICAL_TRIALS
trial_result
· 2012-02-28
Clinical Trial Update: Efficacy and Safety Study of TAK-128 in Treating Subjects With Diabetic Peripheral Neuropathy [Phase 2]
Summary
Phase 2 trial evaluating TAK-128 for diabetic peripheral neuropathy has completed, focusing on efficacy and safety.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Takeda | Conditions: Diabetic Neuropathies | Phase 2 | Status: COMPLETED